SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "swepub ;conttype:(scientificother);lar1:(umu);srt2:(2000-2004)"

Sökning: swepub > Övrigt vetenskapligt/konstnärligt > Umeå universitet > (2000-2004)

  • Resultat 1-10 av 2231
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Schölin, Anna, et al. (författare)
  • Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults : a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden
  • 2004
  • Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 255:3, s. 384-391
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • ObjectivesTo establish the prevalence of remaining β-cell function 8 years after diagnosis of diabetes in young adults and relate the findings to islet antibodies at diagnosis and 8 years later.DesignPopulation-based cohort study.SettingNationwide from all Departments of Medicine and Endocrinology in Sweden.SubjectsA total of 312 young (15–34 years old) adults diagnosed with diabetes during 1987–88.Main outcome measurePlasma connecting peptide (C-peptide) 8 years after diagnosis. Preserved β-cell function was defined as measurable C-peptide levels. Three islet antibodies – cytoplasmic islet cell antibodies (ICA), glutamic acid decarboxylase antibodies and tyrosine phosphatase antibodies – were measured.ResultsAmongst 269 islet antibody positives (ab+) at diagnosis, preserved β-cell function was found in 16% (42/269) 8 years later and these patients had a higher body mass index (median 22.7 and 20.5 kg m−2, respectively; P = 0.0003), an increased frequency of one islet antibody (50 and 24%, respectively; P = 0.001), and a lower prevalence of ICA (55 and 6%, respectively; P = 0.007) at diagnosis compared with ab+ without remaining β-cell function. Amongst the 241 patients without detectable β-cell function at follow-up, 14 lacked islet antibodies, both at diagnosis and at follow-up.ConclusionsSixteen per cent of patients with autoimmune type 1 diabetes had remaining β-cell function 8 years after diagnosis whereas 5.8% with β-cell failure lacked islet autoimmunity, both at diagnosis and at follow-up.
  •  
2.
  • Schölin, Anna, et al. (författare)
  • Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes
  • 2004
  • Ingår i: Diabetic Medicine. - : Wiley. - 0742-3071 .- 1464-5491. ; 21:5, s. 447-455
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Aim To identify clinical, immunological and biochemical factors that predict remission, and its duration in a large cohort of young adults with Type 1 diabetes mellitus (DM).Methods In Sweden, 362 patients (15–34 years), classified as Type 1 DM were included in a prospective, nation-wide population-based study. All patients were followed at local hospitals for examination of HbA1c and insulin dosage over a median period after diagnosis of 5 years. Duration of remission, defined as an insulin maintenance dose ≤ 0.3 U/kg/24 h and HbA1c within the normal range, was analysed in relation to characteristics at diagnosis.Results Remissions were seen in 43% of the patients with a median duration of 8 months (range 1–73). Sixteen per cent had a remission with a duration > 12 months. Among patients with antibodies (ab+), bivariate analysis suggested that adult age, absence of low BMI, high plasma C-peptide concentrations, lack of ketonuria or ketoacidosis at diagnosis and low insulin dose at discharge from hospital were associated with a high possibility of achieving remission. Multiple regression showed that normal weight (BMI of 20–24.9 kg/m2) was the only factor that remained significant for the possibility of entering remission. In survival analysis among ab+ remitters, a low number of islet antibodies, one or two instead of three or four, were associated with a long duration of remissions.Conclusion In islet antibody-positive Type 1 DM, normal body weight was the strongest factor for entering remission, whilst a low number of islet antibodies was of importance for the duration.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Tegnell, Anders, et al. (författare)
  • [Anthrax : the Swedish perspective]
  • 2001
  • Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 98, s. 5742-
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • The recent occurrence in the USA of deliberate release of virulent Bacillus anthracis in letters sent to three media corporations and to the American senate has led to a great anxiety in Sweden and elsewhere in Europe. Numerous letters have been suspected to contain B. anthracis spores and several have contained powder of different types. In none of the tested letters collected by the Swedish police have we been able to detect anthrax bacilli. Powder containing letters have been tested with either bacterial isolation and/or B. anthracis specific PCR. Anthrax is a disease found naturally in herbivores and is occasionally spread to humans. It is caused by the gram-positive rod B. anthracis that was discovered by Robert Koch in 1876. Beginning in the 1930s many states have developed B. anthracis for use as a weapon. A few releases of the bacteria have been reported before October 2001. B. anthracis causes three forms of disease, cutaneous, pulmonary and gastro-intestinal. The pulmonary form is the most dangerous and may lead to death merely one to two days after onset of severe symptoms. This is due to the rapid growth and release of several potent toxins that engage the immune system and promote tissue destruction. B. anthracis infection can be treated with several antibiotics, among which quinolones and tetracyclins have been recommended. Diagnosis can readily be achieved by microscopy, bacterial isolation and PCR at the Swedish Institute for Infectious Disease Control and the Swedish Defence Research Agency. Antibiotics relevant for treatment of B. anthracis infections are already stockpilled in our country. Further actions to strengthen our capability to deal with bioterrorism are ongoing.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 2231
Typ av publikation
bokkapitel (524)
doktorsavhandling (505)
rapport (357)
tidskriftsartikel (319)
konferensbidrag (264)
bok (71)
visa fler...
samlingsverk (redaktörskap) (62)
recension (58)
licentiatavhandling (43)
annan publikation (13)
proceedings (redaktörskap) (8)
forskningsöversikt (7)
visa färre...
Typ av innehåll
övrigt vetenskapligt/konstnärligt  (2231)Ta bort avgränsningen
Författare/redaktör
Puu, Tönu, 1936- (23)
Söderström, Tor (20)
Segerholm, Christina (19)
Westin, Kerstin, 195 ... (18)
Vikström, Lotta, 197 ... (15)
Edström, Örjan (14)
visa fler...
Börlin, Niclas, 1968 ... (14)
Dahlström, Lars (12)
Bergman, Torbjörn (12)
Lantto, Patrik, 1968 ... (12)
Müller, Dieter K (11)
Johansson, Eva (11)
Holmgren, Carina (11)
Bejstam, Lars (11)
Blom, Björn (11)
Marell, Agneta, 1964 ... (11)
Sporre, Karin (11)
Persson, Per (10)
Lindgren, Urban (10)
Tysklind, Mats (10)
Straarup, Jørgen, 19 ... (10)
Gunnarsson, Åsa (10)
Hult, Agneta (10)
Erixon, Per-Olof, 19 ... (10)
Burman, Monica (10)
Jansson, Bruno (10)
Elenius, Lars, 1952- (10)
Hamilton, David (10)
Lundberg, Johan, 196 ... (9)
From, Jörgen, 1966- (9)
Ågren, Karin (9)
Lövgren, Lars (9)
Wiberg, Britt (9)
Niemi-Kiesiläinen, J ... (9)
Ramqvist, Per H, 195 ... (9)
Ivarsson, Anneli (9)
Bergman, Mats (9)
Viklund, Karin (9)
Dahlgren, Ethel (9)
Forsberg, Bertil (8)
Gardini, Laura (8)
Andersson, Håkan (8)
Gröbner, Gerhard (8)
Lundström, Jan-Erik (8)
Belyaev, Yuri K (8)
Berge, Britt-Marie (8)
Edlund, Lars-Erik (8)
Sushko, Irina (8)
Garvill, Jörgen (8)
Lindqvist, Rafael, 1 ... (8)
visa färre...
Lärosäte
Umeå universitet  (2231)Ta bort avgränsningen
Uppsala universitet (56)
Mittuniversitetet (29)
Luleå tekniska universitet (28)
Södertörns högskola (22)
Högskolan Dalarna (19)
visa fler...
Linköpings universitet (16)
Stockholms universitet (15)
Göteborgs universitet (14)
Lunds universitet (13)
Högskolan i Gävle (12)
Naturvårdsverket (9)
Linnéuniversitetet (9)
Karolinska Institutet (9)
Jönköping University (4)
Blekinge Tekniska Högskola (4)
Kungliga Tekniska Högskolan (3)
Örebro universitet (3)
Högskolan i Halmstad (2)
Mälardalens universitet (2)
Karlstads universitet (2)
Malmö universitet (1)
Chalmers tekniska högskola (1)
Högskolan i Borås (1)
Riksantikvarieämbetet (1)
Försvarshögskolan (1)
visa färre...
Språk
Engelska (1151)
Svenska (1044)
Tyska (15)
Odefinierat språk (9)
Franska (5)
Norska (3)
visa fler...
Finska (2)
Ryska (1)
Spanska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Samhällsvetenskap (560)
Humaniora (469)
Naturvetenskap (186)
Medicin och hälsovetenskap (172)
Teknik (21)
Lantbruksvetenskap (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy